Loading...

Health SA

MLAHC.PAEURONEXT
Healthcare
Medical - Diagnostics & Research
0.60
0.00(0.00%)

Health SA MLAHC.PA Peers

See (MLAHC.PA) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MLAHC.PA€0.60+0.00%5.4M-10.00-€0.06N/A
BIM.PA€119.10+0.59%14B32.72€3.64+0.76%
ERF.PA€63.36+2.89%11.1B30.32€2.09+0.95%
LBIRD.PA€18.60-1.06%409.4M71.54€0.26N/A
ALECR.PA€17,800.00+0.00%89.8M12.55€1,418.84N/A
MDXH.BR€3.02-3.76%85.6M-1.58-€1.91N/A
BCART.BR€0.29+0.00%27.2M-0.32-€0.92N/A
ALBIO.PA€1.22-1.61%22.2M-0.37-€3.29N/A
ALPRE.PA€3.58+3.77%13.4M-3.01-€1.19N/A
EEP.MC€0.54N/A6.3M-54.00-€0.01N/A
Showing 1 to 10 of 11 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MLAHC.PA vs BIM.PA Comparison

MLAHC.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLAHC.PA stands at 5.4M. In comparison, BIM.PA has a market cap of 14B. Regarding current trading prices, MLAHC.PA is priced at €0.60, while BIM.PA trades at €119.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLAHC.PA currently has a P/E ratio of -10.00, whereas BIM.PA's P/E ratio is 32.72. In terms of profitability, MLAHC.PA's ROE is N/A, compared to BIM.PA's ROE of +0.11%. Regarding short-term risk, MLAHC.PA is less volatile compared to BIM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for MLAHC.PA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;